Fri, December 13, 2019
Thu, December 12, 2019
Wed, December 11, 2019

Chris Schott Upgraded (BHC) to Buy and Increased Target to $38 on, Dec 12th, 2019

Chris Schott of JP Morgan, Upgraded "Bausch Health Companies Inc." (BHC) to Buy and Increased Target from $32 to $38 on, Dec 12th, 2019.

Chris has made no other calls on BHC in the last 4 months.



There is 1 other peer that has a rating on BHC. Out of the 1 peers that are also analyzing BHC, 0 agree with Chris's Rating of Hold.



This is the rating of the analyst that currently disagrees with Chris


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $60 on, Monday, December 2nd, 2019